A senate committee has delayed its vote on President Donald Trump’s choice to oversee the United States drug and medical device approval agency.
Scott Gottlieb, tapped to be commissioner of the Food and Drug Administration, will now have to wait for a confirmation vote by the senate’s health, education, labor and pensions committee. Committee chairman Lamar Alexander, Republican of Tennessee, said lawmakers needed more time to gather information about Gottlieb, rescheduling the vote for 27 April. With republicans controlling the committee and the senate, he is expected to be approved.
The FDA is part of the Department of Health and Human Services, which also houses the National Institutes of Health. The agency regulates the safety of pharmaceuticals, medical devices, some foods and other products that humans and animals come into close contact with. It’s nearly $1-billion annual budget is funded largely by fees collected from drug companies.
This article is only available to Research Professional News subscribers or Pivot-RP users.
If you are a Research Professional News subscriber you can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.